Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: OVID

Ovid Therapeutics Inc.

Healthcare | Biotechnology

No licensed closing price on file for OVID. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Ovid Therapeutics Inc. (NASDAQ: OVID) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 23:42 UTC.

What Ovid Therapeutics Inc. does

Ovid is a biopharmaceutical company developing small molecule medicines for brain disorders characterized by neuronal hyperexcitation, including epilepsies, psychoses, and related conditions. The company targets fundamental biological mechanisms such as neurotransmitters and ion channels to create drugs with differentiated mechanisms of action.

Summarized from Ovid Therapeutics Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-13.33%

Revenue, margins & earnings

FY2021 Net income: $123MFY2021 Operating costs: $84M$208MFY2021FY2022: net loss $54M on revenue $2M$2MFY2022FY2023: net loss $52M on revenue $392,000$392,000FY2023FY2024: net loss $26M on revenue $566,000$566,000FY2024FY2025: net loss $17M on revenue $7M$7MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-07-08
Most recent filed transactions — July 2026:
  • 2026-07-08Chief Financial OfficerAward50,000—
  • 2026-06-17DirectorStock Option (right to buy)Award130,000—
  • 2026-04-09DirectorAward8,789$22.5K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Ovid Therapeutics Inc. do?

Ovid is a biopharmaceutical company developing small molecule medicines for brain disorders characterized by neuronal hyperexcitation, including epilepsies, psychoses, and related conditions.

When did OVID last file with the SEC?

Ovid Therapeutics Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-08. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 23:42 UTC. This page is also available as JSON at /api/data?ticker=OVID and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for OVID and 5,000+ tickers.

Create a free account — keep OVID
For your agent
GET /api/data?ticker=OVID

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt